Everyone’s talking about weight loss drugs like Ozempic, Wegovy and Mounjaro and their implications on weight loss – but their benefits go way beyond that.

KUALA LUMPUR, Jan 15 — Novo Nordisk today announced that its weight-loss drug, Wegovy (semaglutide 2.4mg), is now officially available in Malaysia, offering a new

Kim Kyung-ah, president and CEO of Samsung Epis Holdings and Samsung Bioepis, answers questions from the Korean reporters at a press event held on the

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference  CNBC On Day 3 of JPM, pharma threads a needle with

Celltrion CEO Seo Jin-seok delivers a keynote speech on the company’s future road map at the 44th J.P. Morgan Health Care Conference held in San

GLP-1 receptor agonists were initially developed to treat type 2 diabetes and have had a transformative effect on its therapy, and are highly effective for

Years after approving three glucagon-like peptide-1 (GLP-1) receptor agonists to treat obesity, the U.S. FDA is acknowledging that the drugs don’t have the same risk

From nausea to emotional shifts to unexpected changes in how people treat you, we want the side of GLP-1s you don’t usually hear about. View

(MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and fewer serious non-cancer

Structure expects pills to capture 25% to 50% of GLP-1 obesity market by 2030 (www.reuters.com) 04:00  

These will help you build a supportive foundation for the body.

The Food and Drug Administration said Tuesday that it wants suicide warning labels on GLP-1 weight-loss drugs to be removed.

From GLP-1 to Keto, hear the nutrition tips and recipes you need to stay on track in the New Year IRVING, Texas, Jan. 14, 2026

Post Content

But the labels — unlike the popular medications themselves — aren’t regulated by the FDA.

by Ariana M. Chao, Adam Gilden, Thomas A. Wadden Glucagon-like peptide-1 (GLP-1)-based medications, such as semaglutide and tirzepatide, have transformed obesity care. However, rising use

The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value in recent years.

Novo Nordisk’s CEO spoke about GLP-1 pricing and Pfizer’s CEO spoke about the company’s obesity ambitions while at the JPMorgan Healthcare Conference.

We have heard Reddit horror stories about GLP-1 users losing their hair. Now, there’s finally a study corroborating these claims. The researchers concluded that patients

In the three years since Ozempic entered the national consciousness, the brand name has become so ubiquitous that it is used as a shorthand for

While the nutritional needs of GLP-1 users are not drastically different from the general population, according to a dietician, the key distinction lies in reduced

WEDNESDAY, Jan. 14, 2026 — More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like peptide-1

Bariatric surgery and GLP-1 treatments reshape body composition differently, emphasizing the importance of sex and treatment choice in muscle preservation.

The rise and riseof GLP-1 medications, why lived experiences are important in the context of mental health and why the new US dietary guidelines should

Brand hopes chef can boost appeal among nutrient-conscious foodies.

SALT LAKE CITY, Jan. 14, 2026 /PRNewswire/ — Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of

Research shows that people who stop taking GLP-1 medications regain weight within 2 years. Image Credit: Tatsiana Volkava/Getty Images A new study has found that

Good morning, everyone, the middle of the week has arrived and this calls for a celebratory cup or two of stimulation. How so? Well, you

South Africa is a study in contrasts. And the 2026 public health agenda is no exception.  Breakthrough HIV prevention medicine has arrived alongside US funding

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out for 2026,

Tucker Carlson’s gaunt appearance sparks Ozempic rumours as weight-loss drugs become mainstream. Explore the latest speculation and why celebrities are turning to GLP-1 medications.

The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy (semaglutide)

Food Funct., 2026, Advance ArticleDOI: 10.1039/D6FO90005D, Correction Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Hong Hu, Jie

Texas-founded partnership debuts a 12-week GLP-1 + food-as-medicine program built for sustainable metabolic health and employer-ready deployment AUSTIN, Texas, Jan. 14, 2026 /PRNewswire/ — Nimbus

Dr Bhojraj explains that GLP-1 isn’t a medication but a natural hormone, and while it can help, they have side effects and aren’t meant for